215
Views
18
CrossRef citations to date
0
Altmetric
Articles

High-dimensional QSAR modelling using penalized linear regression model with L1/2-norm

, , &
Pages 703-719 | Received 04 Jun 2016, Accepted 22 Aug 2016, Published online: 14 Sep 2016

References

  • A.M. Al-Fakih, M. Aziz, H.H. Abdallah, Z.Y. Algamal, M.H. Lee, and H. Maarof, High dimensional QSAR study of mild steel corrosion inhibition in acidic medium by furan derivatives, Int. J. Electrochemsc. 10 (2015), pp. 3568–3583.
  • Z.Y. Algamal, M.H. Lee, A.M. Al-Fakih, and M. Aziz, High-dimensional QSAR prediction of anticancer potency of imidazo[4,5-b]pyridine derivatives using adjusted adaptive LASSO, J. Chemom. 29 (2015), pp. 547–556.
  • J. Huang and X. Fan, Reliably assessing prediction reliability for high dimensional QSAR data, Mol. Divers. 17 (2013), pp. 63–73.
  • K. Zhang, J.M. Hughes-Oliver, and S.S. Young, Analysis of high-dimensional structure-activity screening datasets using the optimal bit string tree, Technometrics 55 (2013), pp. 161–173.
  • R. Todeschini, V. Consonni, A. Mauri, and M. Pavan, Dragon 6, 2012.
  • S. Gupta, N. Basant, and K.P. Singh, Qualitative and quantitative structure-activity relationship modelling for predicting blood-brain barrier permeability of structurally diverse chemicals, SAR QSAR Environ. Res. 26 (2015), pp. 95–124.
  • A.M. Al-Fakih, Z.Y. Algamal, M.H. Lee, H.H. Abdallah, H. Maarof, and M. Aziz, Quantitative structure-activity relationship model for prediction study of corrosion inhibition efficiency using two-stage sparse multiple linear regression, J. Chemom. 30 (2016), pp. 361–368.
  • C. Nantasenamat, T. Monnor, A. Worachartcheewan, P. Mandi, C. Isarankura-Na-Ayudhya, and V. Prachayasittikul, Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection, Eur. J. Med. Chem. 76 (2014), pp. 352–359.
  • E. Pourbasheer, R. Aalizadeh, T.S. Shokouhi, M.R. Ganjali, P. Norouzi, and J. Shadmanesh, 2D and 3D quantitative structure–activity relationship study of hepatitis C virus NS5B polymerase inhibitors by comparative molecular field analysis and comparative molecular similarity indices analysis methods, J. Chem. Inf. Model. 54 (2014), pp. 2902–2914.
  • Z.Y. Algamal, M.H. Lee, and A.M. Al-Fakih, High-dimensional quantitative structure–activity relationship modeling of influenza neuraminidase A/PR/8/34 (H1N1) inhibitors based on a two-stage adaptive penalized rank regression, J. Chemom. 30 (2016), pp. 50–57.
  • P. Filzmoser, M. Gschwandtner, and V. Todorov, Review of sparse methods in regression and classification with application to chemometrics, J. Chemom. 26 (2012), pp. 42–51.
  • I.E. Frank and J.H. Friedman, A statistical view of some chemometrics regression tools, Technometrics 35 (1993), pp. 109–135.
  • R. Tibshirani, Regression shrinkage and selection via the Lasso, J. Roy. Statist. Soc. Ser. B 58 (1996), pp. 267–288.
  • J. Fan and R. Li, Variable selection via nonconcave penalized likelihood and its oracle properties, J. Am. Stat. Assoc. 96 (2001), pp. 1348–1360.
  • H. Zou and T. Hastie, Regularization and variable selection via the elastic net, J. Roy. Statist. Soc. Ser. B 67 (2005), pp. 301–320.
  • H. Zou, The adaptive lasso and its oracle properties, J. Am. Stat. Assoc. 101 (2006), pp. 1418–1429.
  • C.J.F. Ter Braak, Regression by L1 regularization of smart contrasts and sums (ROSCAS) beats PLS and elastic net in latent variable model, J. Chemom. 23 (2009), pp. 217–228.
  • M.A. Rasmussen and R. Bro, A tutorial on the Lasso approach to sparse modeling, Chemom. Intell. Lab. Syst. 119 (2012), pp. 21–31.
  • H. Zou and H.H. Zhang, On the adaptive elastic-net with a diverging number of parameters, Ann. Stat. 37 (2009), pp. 1733–1751.
  • C. Park and Y.J. Yoon, Bridge regression- adaptivity and group selection, J. Stat. Plan. Infer. 141 (2011), pp. 3506–3519.
  • W.J. Fu, Penalized regressions: The bridge versus the Lasso, J. Comput. Graph. Stat. 7 (1998), pp. 397–416.
  • K. Knight and W. Fu, Asymptotics for Lasso-type estimators, Ann. Stat. 28 (2000), pp. 1356–1378.
  • J. Huang, J.L. Horowitz, and S. Ma, Asymptotic properties of bridge estimators in sparse high-dimensional regression models, Ann. Stat. 36 (2008), pp. 587–613.
  • J. Huang, S. Ma, H. Xie, and C.-H. Zhang, A group bridge approach for variable selection, Biometrika 96 (2009), pp. 339–355.
  • M. Wang, L. Song, and X. Wang, Bridge estimation for generalized linear models with a diverging number of parameters, Stat. Prob. Lett. 80 (2010), pp. 1584–1596.
  • Y. Liang, C. Liu, X.-Z. Luan, K.-S. Leung, T.-M. Chan, Z.-B. Xu, and H. Zhang, Sparse logistic regression with a L1/2 penalty for gene selection in cancer classification, BMC Bioinformatics 14 (2013), pp. 198–207.
  • H. Zou and R. Li, One-step sparse estimates in nonconcave penalized likelihood models, Ann. Stat. 36 (2008), pp. 1509–1533.
  • B. Efron, T. Hastie, I. Johnstone, and R. Tibshirani, Least angle regression, Ann. Stat. 32 (2004), pp. 407–499.
  • S. Kawano, Selection of tuning parameters in bridge regression models via Bayesian information criterion, Statis. Paper. 55 (2014), pp. 1207–1223.
  • Z.Y. Algamal and M.H. Lee, Regularized logistic regression with adjusted adaptive elastic net for gene selection in high dimensional cancer classification, Comput. Biol. Med. 67 (2015), pp. 136–145.
  • Z.Y. Algamal and M.H. Lee, Penalized logistic regression with the adaptive LASSO for gene selection in high-dimensional cancer classification, Expe. Syst. Appl. 42 (2015), pp. 9326–9332.
  • C.R. Garcia-Jacas, E. Contreras-Torres, Y. Marrero-Ponce, M. Pupo-Merino, S.J. Barigye, and L. Cabrera-Leyva, Examining the predictive accuracy of the novel 3D N-linear algebraic molecular codifications on benchmark datasets, J. Cheminform. 8 (2016), p. 10.
  • J.J. Sutherland, L.A. O'Brien, and D.F. Weaver, A comparison of methods for modeling quantitative structure–activity relationships, J. Med. Chem. 47 (2004), pp. 5541–5554.
  • B.M. Bababdani and M. Mousavi, Gravitational search algorithm: A new feature selection method for QSAR study of anticancer potency of imidazo[4,5-b]pyridine derivatives, Chemom. Intell. Lab. Syst. 122 (2013), pp. 1–11.
  • V. Bavetsias, S. Crumpler, C. Sun, S. Avery, B. Atrash, A. Faisal, A.S. Moore, M. Kosmopoulou, N. Brown, P.W. Sheldrake, K. Bush, A. Henley, G. Box, M. Valenti, A. De Haven Brandon, F.I. Raynaud, P. Workman, S.A. Eccles, R. Bayliss, S. Linardopoulos, and J. Blagg, Optimization of imidazo[4,5-B]pyridine-based kinase inhibitors: Identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia, J. Med. Chem. 55 (2012), pp. 8721–8734.
  • V. Bavetsias, A. Faisal, S. Crumpler, N. Brown, M. Kosmopoulou, A. Joshi, B. Atrash, Y. Pérez-Fuertes, J.A. Schmitt, K.J. Boxall, R. Burke, C. Sun, S. Avery, K. Bush, A. Henley, F.I. Raynaud, P. Workman, R. Bayliss, S. Linardopoulos, and J. Blagg, Aurora isoform selectivity: Design and synthesis of imidazo[4,5-B]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells, J. Med. Chem. 56 (2013), pp. 9122–9135.
  • V. Bavetsias, J.M. Large, C. Sun, N. Bouloc, M. Kosmopoulou, M. Matteucci, N.E. Wilsher, V. Martins, J.H. Reynisson, B. Atrash, A. Faisal, F. Urban, M. Valenti, A. De Haven Brandon, G. Box, F.I. Raynaud, P. Workman, S.A. Eccles, R. Bayliss, J. Blagg, S. Linardopoulos, and E. Mcdonald, Imidazo[4,5-B]pyridine derivatives as inhibitors of aurora kinases: Lead optimization studies toward the identification of an orally bioavailable preclinical development candidate, J. Med. Chem. 53 (2010), pp. 5213–5228.
  • P. Lan, W.-N. Chen, and W.-M. Chen, Molecular modeling studies on imidazo[4,5-B]pyridine derivatives as aurora A kinase inhibitors using 3D-QSAR and docking approaches, Eur. J. Med. Chem. 46 (2011), pp. 77–94.
  • A. Khazaei, N. Sarmasti, J.Y. Seyf, Z. Rostami, and M.A. Zolfigol, QSAR study of the non-peptidic inhibitors of procollagen C-proteinase based on multiple linear regression, principle component regression, and partial least squares, Arabian J. Chem. (2015), pp. 151–164.
  • E. Turtle, N. Chow, C. Yang, S. Sosa, U. Bauer, M. Brenner, D. Solow-Cordero, and W.B. Ho, Design and synthesis of procollagen C-proteinase inhibitors, Bioorg. Med. Chem. Lett. 22 (2012), pp. 7397–7401.
  • P. Gramatica and A. Sangion, A historical excursus on the statistical validation parameters for QSAR models: A clarification concerning metrics and terminology, J. Chem. Inf. Model. 56 (2016), pp. 1127–1131.
  • J. Fan and J. Lv, Sure independence screening for ultra-high-dimensional feature space, J. Roy. Statist. Soc. Ser. B 70 (2008), pp. 849–911.
  • E. Borges De Melo and J.P. Ataide Martins, T.C. Marinho Jorge, M.C. Friozi, and M.M. Castro Ferreira, Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98, Eur. J. Med. Chem. 45 (2010), pp. 4562–4569.
  • R. Kiralj and M.M.C. Ferreira, Basic validation procedures for regression models in QSAR And QSPR studies – Theory and application, J. Braz. Chem. Soc. 20 (2009), pp. 770–787.
  • R. Kiralj and M.M.C. Ferreira, Is your QSAR/QSPR descriptor real or trash?, J. Chemom. 24 (2010), pp. 681–693.
  • P. Gramatica, Principles of QSAR models validation: Internal and external, QSAR Comb. Sci. 26 (2007), pp. 694–701.
  • C. Rücker, G. Rücker, and M. Meringer, Y-randomization and its variants in QSPR/QSAR, J. Chem. Inf. Model. 47 (2007), pp. 2345–2357.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.